drugset / Trial / NCT05402852
Effectiveness and Safety of EuBone® Capsules for Bone Health in Postmenopausal Women
Phase 4
Unknown
30 enrolled
Shandong University
Chenland Nutritionals lnc. · collabJinan Hetai Pharmaceutical Technology Co., LTD · collabQianfoshan Hospital · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
EuBone is prepared by mixing eucommia ulmoides extract, fructus ulmoides extract and dodder extract in proportion. The aim of this study is to evaluate the effectiveness and safety of EuBone® capsules in slowing bone loss, preventing bone loss, and improving quality of life compared with placebo in Postmenopausal women.
Timeline
- Start
- 2022-06-01
- Primary completion
- 2022-10-31
- Completion
- 2023-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | EuBone | Unknown | 500 mg | — |